Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.397256593755835.
The log-likelihood improved by 3.024.
Iteration 2 of at most 500:
Optimizing with step length 0.754446031847311.
The log-likelihood improved by 3.464.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.3545.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.93.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       3       23     1173     1023      786      376      350      366 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     310      245      151       94       52       29       10        5 
degree16 degree17 
       3        1 
1 
disease_progression 
H-positive risk:  881 900 119 902 431 126 854 436 98 57 121 75 
H-negative risk:  900 881 854 902 436 431 126 119 121 98 75 57 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
61 new agents 
2 
disease_progression 
H-positive risk:  880 902 121 904 428 125 860 428 98 55 124 75 
H-negative risk:  902 880 860 904 428 428 125 121 124 98 75 55 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
3 
disease_progression 
H-positive risk:  883 912 120 906 423 125 860 422 94 56 125 74 
H-negative risk:  912 883 860 906 422 423 125 120 125 94 74 56 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 8 

clinical_engagement 
diagnosis 
demography 
55 new agents 
4 
disease_progression 
H-positive risk:  889 913 123 901 422 127 863 415 91 56 125 75 
H-negative risk:  913 889 863 901 415 422 127 123 125 91 75 56 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 10 

clinical_engagement 
diagnosis 
demography 
57 new agents 
5 
disease_progression 
H-positive risk:  886 919 124 905 418 126 866 408 90 57 126 75 
H-negative risk:  919 886 866 905 408 418 126 124 126 90 75 57 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 11 

clinical_engagement 
diagnosis 
demography 
56 new agents 
6 
disease_progression 
H-positive risk:  900 917 125 909 419 126 861 404 84 57 125 73 
H-negative risk:  917 900 861 909 404 419 126 125 125 84 73 57 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
7 
disease_progression 
H-positive risk:  911 916 127 910 414 127 856 404 84 55 127 69 
H-negative risk:  916 911 856 910 404 414 127 127 127 84 69 55 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
8 
disease_progression 
H-positive risk:  914 927 129 907 411 127 849 402 85 55 127 67 
H-negative risk:  927 914 849 907 402 411 127 129 127 85 67 55 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 16 1 

clinical_engagement 
diagnosis 
demography 
64 new agents 
9 
disease_progression 
H-positive risk:  919 935 131 903 404 127 852 394 87 53 128 67 
H-negative risk:  935 919 852 903 394 404 127 131 128 87 67 53 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 17 1 

clinical_engagement 
diagnosis 
demography 
46 new agents 
10 
disease_progression 
H-positive risk:  925 932 130 900 407 126 865 383 87 52 129 64 
H-negative risk:  932 925 865 900 383 407 126 130 129 87 64 52 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 19 1 

clinical_engagement 
diagnosis 
demography 
67 new agents 
11 
disease_progression 
H-positive risk:  929 935 131 902 400 127 867 376 88 50 131 64 
H-negative risk:  935 929 867 902 376 400 127 131 131 88 64 50 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 19 2 

clinical_engagement 
diagnosis 
demography 
58 new agents 
12 
disease_progression 
H-positive risk:  935 943 132 904 396 127 856 373 88 50 132 64 
H-negative risk:  943 935 856 904 373 396 127 132 132 88 64 50 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 22 2 

clinical_engagement 
diagnosis 
demography 
64 new agents 
13 
disease_progression 
H-positive risk:  875 885 123 975 392 118 919 363 94 52 143 61 
H-negative risk:  885 875 919 975 363 392 118 123 143 94 61 52 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 23 2 

clinical_engagement 
diagnosis 
demography 
211 new agents 
14 
disease_progression 
H-positive risk:  909 925 130 929 398 121 863 380 95 49 138 63 
H-negative risk:  925 909 863 929 380 398 121 130 138 95 63 49 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 23 2 

clinical_engagement 
diagnosis 
demography 
62 new agents 
15 
disease_progression 
H-positive risk:  918 921 133 929 393 121 861 382 95 48 138 61 
H-negative risk:  921 918 861 929 382 393 121 133 138 95 61 48 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 24 2 

clinical_engagement 
diagnosis 
demography 
59 new agents 
16 
disease_progression 
H-positive risk:  933 923 131 920 391 121 860 380 94 46 140 61 
H-negative risk:  923 933 860 920 380 391 121 131 140 94 61 46 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 24 2 

clinical_engagement 
diagnosis 
demography 
60 new agents 
17 
disease_progression 
H-positive risk:  933 936 134 924 387 122 853 375 94 45 138 59 
H-negative risk:  936 933 853 924 375 387 122 134 138 94 59 45 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 23 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
18 
disease_progression 
H-positive risk:  935 940 138 918 386 123 856 366 98 44 137 59 
H-negative risk:  940 935 856 918 366 386 123 138 137 98 59 44 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 23 8 

clinical_engagement 
diagnosis 
demography 
52 new agents 
19 
disease_progression 
H-positive risk:  939 943 138 912 378 125 852 372 100 43 138 60 
H-negative risk:  943 939 852 912 372 378 125 138 138 100 60 43 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 22 8 

clinical_engagement 
diagnosis 
demography 
51 new agents 
20 
disease_progression 
H-positive risk:  939 939 137 917 375 125 855 370 99 46 138 60 
H-negative risk:  939 939 855 917 370 375 125 137 138 99 60 46 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 23 9 

clinical_engagement 
diagnosis 
demography 
63 new agents 
21 
disease_progression 
H-positive risk:  944 947 136 916 373 127 851 363 101 44 137 61 
H-negative risk:  947 944 851 916 363 373 127 136 137 101 61 44 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 24 10 

clinical_engagement 
diagnosis 
demography 
79 new agents 
22 
disease_progression 
H-positive risk:  959 952 134 914 364 129 843 362 101 45 138 59 
H-negative risk:  952 959 843 914 362 364 129 134 138 101 59 45 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 24 9 

clinical_engagement 
diagnosis 
demography 
49 new agents 
23 
disease_progression 
H-positive risk:  958 956 137 907 362 132 844 362 100 44 139 59 
H-negative risk:  956 958 844 907 362 362 132 137 139 100 59 44 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 26 10 

clinical_engagement 
diagnosis 
demography 
53 new agents 
24 
disease_progression 
H-positive risk:  965 949 137 906 361 134 844 360 102 45 139 58 
H-negative risk:  949 965 844 906 360 361 134 137 139 102 58 45 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
62 new agents 
25 
disease_progression 
H-positive risk:  888 867 129 993 357 125 924 356 111 43 147 60 
H-negative risk:  867 888 924 993 356 357 125 129 147 111 60 43 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
186 new agents 
26 
disease_progression 
H-positive risk:  906 884 130 960 381 126 892 357 114 42 146 62 
H-negative risk:  884 906 892 960 357 381 126 130 146 114 62 42 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 29 13 

clinical_engagement 
diagnosis 
demography 
58 new agents 
27 
disease_progression 
H-positive risk:  913 888 130 956 383 125 885 353 116 43 146 62 
H-negative risk:  888 913 885 956 353 383 125 130 146 116 62 43 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 32 14 

clinical_engagement 
diagnosis 
demography 
53 new agents 
28 
disease_progression 
H-positive risk:  921 893 129 953 381 124 887 350 114 42 144 62 
H-negative risk:  893 921 887 953 350 381 124 129 144 114 62 42 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 33 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
29 
disease_progression 
H-positive risk:  923 900 130 955 384 123 879 348 113 43 142 60 
H-negative risk:  900 923 879 955 348 384 123 130 142 113 60 43 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 35 14 

clinical_engagement 
diagnosis 
demography 
61 new agents 
30 
disease_progression 
H-positive risk:  921 900 132 953 382 125 881 346 115 44 141 60 
H-negative risk:  900 921 881 953 346 382 125 132 141 115 60 44 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 35 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
31 
disease_progression 
H-positive risk:  923 904 132 943 378 123 881 350 116 46 143 61 
H-negative risk:  904 923 881 943 350 378 123 132 143 116 61 46 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 35 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
32 
disease_progression 
H-positive risk:  921 907 133 937 373 124 885 348 119 47 146 60 
H-negative risk:  907 921 885 937 348 373 124 133 146 119 60 47 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 39 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
33 
disease_progression 
H-positive risk:  921 907 133 934 374 124 891 346 119 46 143 62 
H-negative risk:  907 921 891 934 346 374 124 133 143 119 62 46 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 39 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
34 
disease_progression 
H-positive risk:  922 916 134 926 378 122 890 344 120 43 141 64 
H-negative risk:  916 922 890 926 344 378 122 134 141 120 64 43 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 40 15 

clinical_engagement 
diagnosis 
demography 
48 new agents 
35 
disease_progression 
H-positive risk:  928 917 134 917 373 122 889 348 121 42 144 65 
H-negative risk:  917 928 889 917 348 373 122 134 144 121 65 42 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 40 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
36 
disease_progression 
H-positive risk:  927 920 134 919 369 119 886 354 124 42 140 66 
H-negative risk:  920 927 886 919 354 369 119 134 140 124 66 42 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 40 14 

clinical_engagement 
diagnosis 
demography 
60 new agents 
37 
disease_progression 
H-positive risk:  883 848 122 995 363 111 931 354 130 42 156 65 
H-negative risk:  848 883 931 995 354 363 111 122 156 130 65 42 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 43 15 

clinical_engagement 
diagnosis 
demography 
156 new agents 
38 
disease_progression 
H-positive risk:  897 870 126 954 394 111 901 365 126 40 151 65 
H-negative risk:  870 897 901 954 365 394 111 126 151 126 65 40 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 45 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
39 
disease_progression 
H-positive risk:  900 868 125 957 393 113 902 365 127 43 145 62 
H-negative risk:  868 900 902 957 365 393 113 125 145 127 62 43 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 50 15 

clinical_engagement 
diagnosis 
demography 
61 new agents 
40 
disease_progression 
H-positive risk:  902 867 124 960 389 112 907 364 128 40 146 61 
H-negative risk:  867 902 907 960 364 389 112 124 146 128 61 40 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 50 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
41 
disease_progression 
H-positive risk:  903 873 125 959 382 112 910 365 127 40 145 59 
H-negative risk:  873 903 910 959 365 382 112 125 145 127 59 40 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 51 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
42 
disease_progression 
H-positive risk:  905 871 126 962 382 111 915 362 125 34 147 60 
H-negative risk:  871 905 915 962 362 382 111 126 147 125 60 34 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 56 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
43 
disease_progression 
H-positive risk:  901 877 127 955 383 113 918 361 124 35 147 59 
H-negative risk:  877 901 918 955 361 383 113 127 147 124 59 35 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 59 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
44 
disease_progression 
H-positive risk:  903 880 122 957 380 111 932 355 124 33 146 57 
H-negative risk:  880 903 932 957 355 380 111 122 146 124 57 33 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 63 16 

clinical_engagement 
diagnosis 
demography 
47 new agents 
45 
disease_progression 
H-positive risk:  905 882 123 949 382 109 932 355 125 33 147 58 
H-negative risk:  882 905 932 949 355 382 109 123 147 125 58 33 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 63 19 

clinical_engagement 
diagnosis 
demography 
51 new agents 
46 
disease_progression 
H-positive risk:  907 882 123 947 383 110 931 353 125 33 147 59 
H-negative risk:  882 907 931 947 353 383 110 123 147 125 59 33 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 64 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
47 
disease_progression 
H-positive risk:  915 886 125 943 376 109 940 346 126 31 145 58 
H-negative risk:  886 915 940 943 346 376 109 125 145 126 58 31 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
48 
disease_progression 
H-positive risk:  915 882 125 949 373 108 940 349 125 30 145 59 
H-negative risk:  882 915 940 949 349 373 108 125 145 125 59 30 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 63 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
49 
disease_progression 
H-positive risk:  860 835 116 996 372 98 1002 342 133 30 157 59 
H-negative risk:  835 860 1002 996 342 372 98 116 157 133 59 30 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
145 new agents 
50 
disease_progression 
H-positive risk:  868 849 116 962 393 101 979 361 127 33 148 63 
H-negative risk:  849 868 979 962 361 393 101 116 148 127 63 33 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
51 
disease_progression 
H-positive risk:  866 852 120 958 394 99 979 361 129 31 143 68 
H-negative risk:  852 866 979 958 361 394 99 120 143 129 68 31 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
54 new agents 
52 
disease_progression 
H-positive risk:  861 854 118 961 391 101 985 359 129 31 141 69 
H-negative risk:  854 861 985 961 359 391 101 118 141 129 69 31 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
53 
disease_progression 
H-positive risk:  868 849 116 963 382 104 990 361 128 30 143 66 
H-negative risk:  849 868 990 963 361 382 104 116 143 128 66 30 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
54 
disease_progression 
H-positive risk:  864 850 116 960 378 106 1006 350 129 31 145 65 
H-negative risk:  850 864 1006 960 350 378 106 116 145 129 65 31 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
47 new agents 
55 
disease_progression 
H-positive risk:  865 856 116 962 381 103 1003 351 128 30 142 63 
H-negative risk:  856 865 1003 962 351 381 103 116 142 128 63 30 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
56 
disease_progression 
H-positive risk:  866 864 120 963 377 104 996 352 124 28 143 63 
H-negative risk:  864 866 996 963 352 377 104 120 143 124 63 28 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
57 
disease_progression 
H-positive risk:  864 864 119 964 383 103 994 355 124 29 141 60 
H-negative risk:  864 864 994 964 355 383 103 119 141 124 60 29 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
48 new agents 
58 
disease_progression 
H-positive risk:  854 865 120 962 385 103 994 360 127 31 140 59 
H-negative risk:  865 854 994 962 360 385 103 120 140 127 59 31 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 65 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
59 
disease_progression 
H-positive risk:  861 869 120 959 379 104 992 362 126 31 138 59 
H-negative risk:  869 861 992 959 362 379 104 120 138 126 59 31 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 65 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
60 
disease_progression 
H-positive risk:  864 867 120 954 377 106 994 368 124 31 137 58 
H-negative risk:  867 864 994 954 368 377 106 120 137 124 58 31 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
61 
disease_progression 
H-positive risk:  803 810 115 1012 382 99 1051 367 128 32 145 56 
H-negative risk:  810 803 1051 1012 367 382 99 115 145 128 56 32 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
126 new agents 
62 
disease_progression 
H-positive risk:  810 817 115 990 394 102 1029 389 130 32 137 55 
H-negative risk:  817 810 1029 990 389 394 102 115 137 130 55 32 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
63 
disease_progression 
H-positive risk:  817 823 116 992 387 105 1026 381 126 33 141 53 
H-negative risk:  823 817 1026 992 381 387 105 116 141 126 53 33 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
64 
disease_progression 
H-positive risk:  819 823 116 990 394 105 1029 374 126 34 138 52 
H-negative risk:  823 819 1029 990 374 394 105 116 138 126 52 34 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
65 
disease_progression 
H-positive risk:  818 822 118 989 392 107 1036 367 124 36 137 54 
H-negative risk:  822 818 1036 989 367 392 107 118 137 124 54 36 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
66 
disease_progression 
H-positive risk:  827 831 116 980 388 107 1040 360 125 38 137 51 
H-negative risk:  831 827 1040 980 360 388 107 116 137 125 51 38 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
67 
disease_progression 
H-positive risk:  834 841 114 983 380 107 1040 354 124 34 135 54 
H-negative risk:  841 834 1040 983 354 380 107 114 135 124 54 34 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
54 new agents 
68 
disease_progression 
H-positive risk:  833 843 114 980 381 107 1047 352 123 33 133 54 
H-negative risk:  843 833 1047 980 352 381 107 114 133 123 54 33 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
69 
disease_progression 
H-positive risk:  841 845 115 977 379 107 1044 352 118 34 134 54 
H-negative risk:  845 841 1044 977 352 379 107 115 134 118 54 34 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
70 
disease_progression 
H-positive risk:  834 848 114 974 381 105 1042 355 123 33 132 59 
H-negative risk:  848 834 1042 974 355 381 105 114 132 123 59 33 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
71 
disease_progression 
H-positive risk:  842 850 111 975 375 103 1038 352 126 33 135 60 
H-negative risk:  850 842 1038 975 352 375 103 111 135 126 60 33 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
72 
disease_progression 
H-positive risk:  843 855 112 966 375 103 1037 354 128 34 135 58 
H-negative risk:  855 843 1037 966 354 375 103 112 135 128 58 34 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
73 
disease_progression 
H-positive risk:  787 797 104 1026 372 100 1095 354 128 36 142 59 
H-negative risk:  797 787 1095 1026 354 372 100 104 142 128 59 36 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
112 new agents 
74 
disease_progression 
H-positive risk:  779 795 105 1009 396 103 1080 365 124 42 142 60 
H-negative risk:  795 779 1080 1009 365 396 103 105 142 124 60 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
75 
disease_progression 
H-positive risk:  783 800 105 1000 404 104 1077 362 121 45 142 57 
H-negative risk:  800 783 1077 1000 362 404 104 105 142 121 57 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
58 new agents 
76 
disease_progression 
H-positive risk:  782 797 106 1006 402 104 1069 367 120 43 146 58 
H-negative risk:  797 782 1069 1006 367 402 104 106 146 120 58 43 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
77 
disease_progression 
H-positive risk:  779 799 106 1008 405 101 1068 374 122 39 142 57 
H-negative risk:  799 779 1068 1008 374 405 101 106 142 122 57 39 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
78 
disease_progression 
H-positive risk:  777 804 109 1010 395 101 1074 376 121 39 142 52 
H-negative risk:  804 777 1074 1010 376 395 101 109 142 121 52 39 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
79 
disease_progression 
H-positive risk:  776 812 112 1004 389 100 1081 373 121 40 140 52 
H-negative risk:  812 776 1081 1004 373 389 100 112 140 121 52 40 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
80 
disease_progression 
H-positive risk:  784 805 114 1004 389 99 1086 371 121 39 140 48 
H-negative risk:  805 784 1086 1004 371 389 99 114 140 121 48 39 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
81 
disease_progression 
H-positive risk:  784 801 115 1008 385 102 1084 372 122 38 142 47 
H-negative risk:  801 784 1084 1008 372 385 102 115 142 122 47 38 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
82 
disease_progression 
H-positive risk:  789 797 117 1011 379 101 1086 374 122 36 141 47 
H-negative risk:  797 789 1086 1011 374 379 101 117 141 122 47 36 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
83 
disease_progression 
H-positive risk:  794 796 120 1009 380 101 1086 365 122 38 141 48 
H-negative risk:  796 794 1086 1009 365 380 101 120 141 122 48 38 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
84 
disease_progression 
H-positive risk:  793 804 118 1010 377 100 1085 366 122 37 140 48 
H-negative risk:  804 793 1085 1010 366 377 100 118 140 122 48 37 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
85 
disease_progression 
H-positive risk:  742 746 111 1070 372 96 1134 366 130 37 148 48 
H-negative risk:  746 742 1134 1070 366 372 96 111 148 130 48 37 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
100 new agents 
86 
disease_progression 
H-positive risk:  738 753 110 1052 393 96 1116 376 122 42 148 54 
H-negative risk:  753 738 1116 1052 376 393 96 110 148 122 54 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
87 
disease_progression 
H-positive risk:  749 755 110 1056 388 96 1103 379 118 44 150 52 
H-negative risk:  755 749 1103 1056 379 388 96 110 150 118 52 44 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
88 
disease_progression 
H-positive risk:  747 755 111 1057 387 98 1100 385 118 42 149 51 
H-negative risk:  755 747 1100 1057 385 387 98 111 149 118 51 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
89 
disease_progression 
H-positive risk:  753 747 109 1062 377 100 1103 391 117 41 150 50 
H-negative risk:  747 753 1103 1062 391 377 100 109 150 117 50 41 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 77 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
90 
disease_progression 
H-positive risk:  751 753 108 1066 373 98 1105 388 118 41 148 51 
H-negative risk:  753 751 1105 1066 388 373 98 108 148 118 51 41 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
61 new agents 
91 
disease_progression 
H-positive risk:  759 752 109 1071 371 95 1106 379 119 40 148 51 
H-negative risk:  752 759 1106 1071 379 371 95 109 148 119 51 40 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 79 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
92 
disease_progression 
H-positive risk:  769 755 109 1079 367 95 1098 374 118 40 146 50 
H-negative risk:  755 769 1098 1079 374 367 95 109 146 118 50 40 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
93 
disease_progression 
H-positive risk:  767 759 104 1077 366 95 1104 370 121 40 146 51 
H-negative risk:  759 767 1104 1077 370 366 95 104 146 121 51 40 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
94 
disease_progression 
H-positive risk:  764 763 103 1080 365 97 1093 376 122 38 149 50 
H-negative risk:  763 764 1093 1080 376 365 97 103 149 122 50 38 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
95 
disease_progression 
H-positive risk:  756 764 101 1081 359 98 1101 376 125 36 151 52 
H-negative risk:  764 756 1101 1081 376 359 98 101 151 125 52 36 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
96 
disease_progression 
H-positive risk:  759 773 105 1068 360 100 1100 372 126 37 149 51 
H-negative risk:  773 759 1100 1068 372 360 100 105 149 126 51 37 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
97 
disease_progression 
H-positive risk:  712 734 101 1108 358 93 1146 376 134 37 150 51 
H-negative risk:  734 712 1146 1108 376 358 93 101 150 134 51 37 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
98 
disease_progression 
H-positive risk:  707 731 99 1097 377 88 1137 388 131 42 151 52 
H-negative risk:  731 707 1137 1097 388 377 88 99 151 131 52 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
99 
disease_progression 
H-positive risk:  703 732 99 1100 380 90 1135 392 131 42 147 49 
H-negative risk:  732 703 1135 1100 392 380 90 99 147 131 49 42 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
100 
disease_progression 
H-positive risk:  699 734 102 1099 374 91 1137 391 133 43 148 49 
H-negative risk:  734 699 1137 1099 391 374 91 102 148 133 49 43 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
101 
disease_progression 
H-positive risk:  697 731 101 1099 376 92 1134 390 133 44 154 49 
H-negative risk:  731 697 1134 1099 390 376 92 101 154 133 49 44 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
102 
disease_progression 
H-positive risk:  698 727 101 1106 374 94 1138 387 130 43 151 51 
H-negative risk:  727 698 1138 1106 387 374 94 101 151 130 51 43 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
103 
disease_progression 
H-positive risk:  696 728 100 1107 377 93 1126 391 130 46 153 53 
H-negative risk:  728 696 1126 1107 391 377 93 100 153 130 53 46 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
104 
disease_progression 
H-positive risk:  693 725 102 1112 373 94 1129 392 128 46 152 54 
H-negative risk:  725 693 1129 1112 392 373 94 102 152 128 54 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
105 
disease_progression 
H-positive risk:  698 728 102 1110 367 96 1127 394 126 45 152 55 
H-negative risk:  728 698 1127 1110 394 367 96 102 152 126 55 45 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
106 
disease_progression 
H-positive risk:  705 724 106 1107 365 98 1124 384 133 46 152 56 
H-negative risk:  724 705 1124 1107 384 365 98 106 152 133 56 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
107 
disease_progression 
H-positive risk:  707 727 105 1105 362 96 1126 385 133 47 151 56 
H-negative risk:  727 707 1126 1105 385 362 96 105 151 133 56 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
108 
disease_progression 
H-positive risk:  714 719 103 1111 359 96 1126 385 133 49 154 51 
H-negative risk:  719 714 1126 1111 385 359 96 103 154 133 51 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
109 
disease_progression 
H-positive risk:  669 673 99 1161 358 93 1170 380 136 49 161 51 
H-negative risk:  673 669 1170 1161 380 358 93 99 161 136 51 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
98 new agents 
110 
disease_progression 
H-positive risk:  666 678 98 1147 368 91 1156 397 135 52 164 48 
H-negative risk:  678 666 1156 1147 397 368 91 98 164 135 48 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
111 
disease_progression 
H-positive risk:  671 681 100 1135 368 92 1151 405 130 55 164 48 
H-negative risk:  681 671 1151 1135 405 368 92 100 164 130 48 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
112 
disease_progression 
H-positive risk:  667 683 100 1141 366 91 1151 401 134 54 165 47 
H-negative risk:  683 667 1151 1141 401 366 91 100 165 134 47 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
113 
disease_progression 
H-positive risk:  667 682 102 1146 358 91 1152 400 136 57 160 49 
H-negative risk:  682 667 1152 1146 400 358 91 102 160 136 49 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
114 
disease_progression 
H-positive risk:  673 684 102 1138 358 94 1143 406 138 58 157 49 
H-negative risk:  684 673 1143 1138 406 358 94 102 157 138 49 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
115 
disease_progression 
H-positive risk:  670 688 104 1143 356 96 1139 401 141 56 159 47 
H-negative risk:  688 670 1139 1143 401 356 96 104 159 141 47 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
116 
disease_progression 
H-positive risk:  671 683 104 1149 358 96 1144 395 139 55 158 48 
H-negative risk:  683 671 1144 1149 395 358 96 104 158 139 48 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
117 
disease_progression 
H-positive risk:  668 679 103 1153 354 95 1153 389 141 55 159 51 
H-negative risk:  679 668 1153 1153 389 354 95 103 159 141 51 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
118 
disease_progression 
H-positive risk:  676 687 102 1153 347 94 1147 386 141 55 160 52 
H-negative risk:  687 676 1147 1153 386 347 94 102 160 141 52 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
119 
disease_progression 
H-positive risk:  677 689 103 1158 342 92 1150 381 140 55 162 51 
H-negative risk:  689 677 1150 1158 381 342 92 103 162 140 51 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
65 new agents 
120 
disease_progression 
H-positive risk:  678 694 103 1150 345 91 1146 387 142 55 159 50 
H-negative risk:  694 678 1146 1150 387 345 91 103 159 142 50 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
121 
disease_progression 
H-positive risk:  628 655 97 1181 352 83 1198 383 152 52 168 51 
H-negative risk:  655 628 1198 1181 383 352 83 97 168 152 51 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
122 
disease_progression 
H-positive risk:  624 651 96 1171 372 83 1185 393 153 52 158 62 
H-negative risk:  651 624 1185 1171 393 372 83 96 158 153 62 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
123 
disease_progression 
H-positive risk:  623 659 96 1168 372 83 1183 396 149 52 158 61 
H-negative risk:  659 623 1183 1168 396 372 83 96 158 149 61 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
124 
disease_progression 
H-positive risk:  624 663 97 1160 375 83 1184 400 144 53 156 61 
H-negative risk:  663 624 1184 1160 400 375 83 97 156 144 61 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
125 
disease_progression 
H-positive risk:  629 664 94 1157 370 79 1186 403 142 58 156 62 
H-negative risk:  664 629 1186 1157 403 370 79 94 156 142 62 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
126 
disease_progression 
H-positive risk:  631 662 94 1162 367 80 1191 399 144 56 153 61 
H-negative risk:  662 631 1191 1162 399 367 80 94 153 144 61 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
127 
disease_progression 
H-positive risk:  633 667 92 1169 371 79 1179 399 142 57 152 60 
H-negative risk:  667 633 1179 1169 399 371 79 92 152 142 60 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
128 
disease_progression 
H-positive risk:  635 668 89 1170 370 78 1187 393 143 55 151 61 
H-negative risk:  668 635 1187 1170 393 370 78 89 151 143 61 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
50 new agents 
129 
disease_progression 
H-positive risk:  633 666 88 1179 368 77 1187 399 140 54 148 61 
H-negative risk:  666 633 1187 1179 399 368 77 88 148 140 61 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
130 
disease_progression 
H-positive risk:  633 679 90 1174 363 75 1184 398 139 55 147 63 
H-negative risk:  679 633 1184 1174 398 363 75 90 147 139 63 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
131 
disease_progression 
H-positive risk:  633 678 87 1174 369 75 1185 391 139 55 149 65 
H-negative risk:  678 633 1185 1174 391 369 75 87 149 139 65 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
132 
disease_progression 
H-positive risk:  634 677 90 1168 376 75 1192 382 140 55 148 63 
H-negative risk:  677 634 1192 1168 382 376 75 90 148 140 63 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
133 
disease_progression 
H-positive risk:  638 675 87 1173 380 78 1182 378 141 54 151 63 
H-negative risk:  675 638 1182 1173 378 380 78 87 151 141 63 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
102 new agents 
134 
disease_progression 
H-positive risk:  640 673 89 1161 380 79 1181 386 142 55 151 63 
H-negative risk:  673 640 1181 1161 386 380 79 89 151 142 63 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
135 
disease_progression 
H-positive risk:  639 672 88 1161 376 78 1184 391 142 59 147 63 
H-negative risk:  672 639 1184 1161 391 376 78 88 147 142 63 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
136 
disease_progression 
H-positive risk:  651 674 91 1144 380 78 1179 392 144 58 146 63 
H-negative risk:  674 651 1179 1144 392 380 78 91 146 144 63 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
137 
disease_progression 
H-positive risk:  649 676 90 1149 379 79 1180 388 138 61 147 64 
H-negative risk:  676 649 1180 1149 388 379 79 90 147 138 64 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
138 
disease_progression 
H-positive risk:  649 675 91 1157 374 81 1176 390 133 60 150 64 
H-negative risk:  675 649 1176 1157 390 374 81 91 150 133 64 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
139 
disease_progression 
H-positive risk:  648 662 95 1162 375 84 1181 390 128 61 149 65 
H-negative risk:  662 648 1181 1162 390 375 84 95 149 128 65 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
140 
disease_progression 
H-positive risk:  642 667 95 1159 377 83 1193 381 128 61 149 65 
H-negative risk:  667 642 1193 1159 381 377 83 95 149 128 65 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
141 
disease_progression 
H-positive risk:  642 660 97 1164 380 86 1190 383 128 59 146 65 
H-negative risk:  660 642 1190 1164 383 380 86 97 146 128 65 59 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
142 
disease_progression 
H-positive risk:  644 652 97 1167 382 86 1194 382 126 57 146 67 
H-negative risk:  652 644 1194 1167 382 382 86 97 146 126 67 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
143 
disease_progression 
H-positive risk:  648 654 100 1153 387 88 1196 379 130 53 145 67 
H-negative risk:  654 648 1196 1153 379 387 88 100 145 130 67 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
144 
disease_progression 
H-positive risk:  658 656 99 1156 374 92 1194 373 132 53 148 65 
H-negative risk:  656 658 1194 1156 373 374 92 99 148 132 65 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
145 
disease_progression 
H-positive risk:  661 652 101 1163 378 94 1184 369 130 56 147 65 
H-negative risk:  652 661 1184 1163 369 378 94 101 147 130 65 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
94 new agents 
146 
disease_progression 
H-positive risk:  654 656 102 1154 391 96 1172 380 133 53 146 63 
H-negative risk:  656 654 1172 1154 380 391 96 102 146 133 63 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
147 
disease_progression 
H-positive risk:  657 645 104 1160 395 98 1170 378 134 52 147 60 
H-negative risk:  645 657 1170 1160 378 395 98 104 147 134 60 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
148 
disease_progression 
H-positive risk:  660 643 105 1155 398 98 1169 380 137 49 147 59 
H-negative risk:  643 660 1169 1155 380 398 98 105 147 137 59 49 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
149 
disease_progression 
H-positive risk:  659 646 103 1153 395 95 1167 383 137 51 152 59 
H-negative risk:  646 659 1167 1153 383 395 95 103 152 137 59 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
150 
disease_progression 
H-positive risk:  659 645 106 1160 389 96 1174 373 138 51 149 60 
H-negative risk:  645 659 1174 1160 373 389 96 106 149 138 60 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
151 
disease_progression 
H-positive risk:  659 647 105 1161 393 96 1159 383 137 52 146 62 
H-negative risk:  647 659 1159 1161 383 393 96 105 146 137 62 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
152 
disease_progression 
H-positive risk:  657 650 106 1149 399 97 1161 385 133 54 146 63 
H-negative risk:  650 657 1161 1149 385 399 97 106 146 133 63 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
153 
disease_progression 
H-positive risk:  660 648 107 1155 393 93 1154 390 134 54 146 66 
H-negative risk:  648 660 1154 1155 390 393 93 107 146 134 66 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 98 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
154 
disease_progression 
H-positive risk:  659 652 108 1145 393 93 1156 391 132 56 149 66 
H-negative risk:  652 659 1156 1145 391 393 93 108 149 132 66 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 98 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  661 653 105 1143 395 94 1154 393 132 54 151 65 
H-negative risk:  653 661 1154 1143 393 395 94 105 151 132 65 54 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
156 
disease_progression 
H-positive risk:  661 647 104 1138 401 97 1161 385 131 55 153 67 
H-negative risk:  647 661 1161 1138 385 401 97 104 153 131 67 55 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 102 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
157 
disease_progression 
H-positive risk:  667 654 104 1135 395 99 1156 386 132 54 150 68 
H-negative risk:  654 667 1156 1135 386 395 99 104 150 132 68 54 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 100 18 

clinical_engagement 
diagnosis 
demography 
94 new agents 
158 
disease_progression 
H-positive risk:  672 653 102 1132 402 98 1153 388 131 53 146 70 
H-negative risk:  653 672 1153 1132 388 402 98 102 146 131 70 53 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 101 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
159 
disease_progression 
H-positive risk:  679 655 101 1120 412 96 1147 393 133 50 149 65 
H-negative risk:  655 679 1147 1120 393 412 96 101 149 133 65 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 104 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
160 
disease_progression 
H-positive risk:  682 653 99 1107 412 97 1144 402 137 50 152 65 
H-negative risk:  653 682 1144 1107 402 412 97 99 152 137 65 50 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 105 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
161 
disease_progression 
H-positive risk:  683 650 99 1107 408 98 1147 403 136 50 152 67 
H-negative risk:  650 683 1147 1107 403 408 98 99 152 136 67 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 97 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
162 
disease_progression 
H-positive risk:  678 655 102 1099 403 97 1155 403 142 49 152 65 
H-negative risk:  655 678 1155 1099 403 403 97 102 152 142 65 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 100 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
163 
disease_progression 
H-positive risk:  674 663 101 1096 390 97 1160 410 142 50 154 63 
H-negative risk:  663 674 1160 1096 410 390 97 101 154 142 63 50 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
164 
disease_progression 
H-positive risk:  680 674 102 1092 394 96 1149 409 141 51 151 61 
H-negative risk:  674 680 1149 1092 409 394 96 102 151 141 61 51 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 98 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
165 
disease_progression 
H-positive risk:  684 683 102 1091 388 99 1152 401 144 51 148 57 
H-negative risk:  683 684 1152 1091 401 388 99 102 148 144 57 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
166 
disease_progression 
H-positive risk:  683 681 102 1089 395 99 1149 403 142 49 151 57 
H-negative risk:  681 683 1149 1089 403 395 99 102 151 142 57 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 95 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
167 
disease_progression 
H-positive risk:  675 681 106 1095 396 97 1153 399 143 50 148 57 
H-negative risk:  681 675 1153 1095 399 396 97 106 148 143 57 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 94 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
168 
disease_progression 
H-positive risk:  673 683 107 1094 392 93 1150 404 146 49 147 62 
H-negative risk:  683 673 1150 1094 404 392 93 107 147 146 62 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
169 
disease_progression 
H-positive risk:  687 675 104 1100 394 91 1142 399 146 48 150 64 
H-negative risk:  675 687 1142 1100 399 394 91 104 150 146 64 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
91 new agents 
170 
disease_progression 
H-positive risk:  686 677 102 1090 401 93 1126 413 145 48 156 63 
H-negative risk:  677 686 1126 1090 413 401 93 102 156 145 63 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
171 
disease_progression 
H-positive risk:  695 675 101 1088 396 94 1116 417 146 50 158 64 
H-negative risk:  675 695 1116 1088 417 396 94 101 158 146 64 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
172 
disease_progression 
H-positive risk:  694 677 103 1081 396 93 1123 413 147 52 157 64 
H-negative risk:  677 694 1123 1081 413 396 93 103 157 147 64 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
87 new agents 
173 
disease_progression 
H-positive risk:  688 682 105 1079 398 92 1124 412 146 52 159 63 
H-negative risk:  682 688 1124 1079 412 398 92 105 159 146 63 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 88 14 

clinical_engagement 
diagnosis 
demography 
64 new agents 
174 
disease_progression 
H-positive risk:  685 684 103 1077 403 93 1120 415 151 51 157 61 
H-negative risk:  684 685 1120 1077 415 403 93 103 157 151 61 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 83 14 

clinical_engagement 
diagnosis 
demography 
64 new agents 
175 
disease_progression 
H-positive risk:  681 687 103 1082 404 90 1118 417 153 49 157 59 
H-negative risk:  687 681 1118 1082 417 404 90 103 157 153 59 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 84 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
176 
disease_progression 
H-positive risk:  680 685 102 1083 403 89 1126 416 154 49 156 57 
H-negative risk:  685 680 1126 1083 416 403 89 102 156 154 57 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 81 14 

clinical_engagement 
diagnosis 
demography 
61 new agents 
177 
disease_progression 
H-positive risk:  677 684 101 1094 403 88 1125 411 158 49 153 57 
H-negative risk:  684 677 1125 1094 411 403 88 101 153 158 57 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
178 
disease_progression 
H-positive risk:  677 677 97 1105 403 90 1120 412 161 48 154 56 
H-negative risk:  677 677 1120 1105 412 403 90 97 154 161 56 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
84 new agents 
179 
disease_progression 
H-positive risk:  680 675 98 1110 395 93 1119 412 162 48 156 52 
H-negative risk:  675 680 1119 1110 412 395 93 98 156 162 52 48 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
180 
disease_progression 
H-positive risk:  678 677 98 1103 402 95 1114 415 159 53 152 54 
H-negative risk:  677 678 1114 1103 415 402 95 98 152 159 54 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
181 
disease_progression 
H-positive risk:  669 670 98 1102 406 91 1120 422 165 52 151 54 
H-negative risk:  670 669 1120 1102 422 406 91 98 151 165 54 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
93 new agents 
182 
disease_progression 
H-positive risk:  672 673 97 1091 415 95 1116 420 162 53 153 53 
H-negative risk:  673 672 1116 1091 420 415 95 97 153 162 53 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 85 15 

clinical_engagement 
diagnosis 
demography 
104 new agents 
183 
disease_progression 
H-positive risk:  680 675 96 1091 406 91 1111 418 164 55 161 52 
H-negative risk:  675 680 1111 1091 418 406 91 96 161 164 52 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
184 
disease_progression 
H-positive risk:  678 679 97 1091 404 92 1114 418 160 54 162 51 
H-negative risk:  679 678 1114 1091 418 404 92 97 162 160 51 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
185 
disease_progression 
H-positive risk:  681 682 97 1088 407 92 1106 421 158 52 164 52 
H-negative risk:  682 681 1106 1088 421 407 92 97 164 158 52 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
186 
disease_progression 
H-positive risk:  679 684 95 1086 415 92 1104 424 158 49 163 51 
H-negative risk:  684 679 1104 1086 424 415 92 95 163 158 51 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 89 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
187 
disease_progression 
H-positive risk:  677 688 94 1083 414 94 1100 424 160 51 163 52 
H-negative risk:  688 677 1100 1083 424 414 94 94 163 160 52 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 90 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
188 
disease_progression 
H-positive risk:  671 695 96 1084 419 95 1099 420 158 49 161 53 
H-negative risk:  695 671 1099 1084 420 419 95 96 161 158 53 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
189 
disease_progression 
H-positive risk:  668 700 95 1089 415 96 1101 412 155 50 165 54 
H-negative risk:  700 668 1101 1089 412 415 96 95 165 155 54 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 91 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
190 
disease_progression 
H-positive risk:  674 696 99 1085 422 95 1093 417 154 49 162 54 
H-negative risk:  696 674 1093 1085 417 422 95 99 162 154 54 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
88 new agents 
191 
disease_progression 
H-positive risk:  672 705 97 1085 426 96 1085 416 152 51 161 54 
H-negative risk:  705 672 1085 1085 416 426 96 97 161 152 54 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 92 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
192 
disease_progression 
H-positive risk:  671 707 99 1074 426 98 1089 419 150 51 161 55 
H-negative risk:  707 671 1089 1074 419 426 98 99 161 150 55 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 94 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
193 
disease_progression 
H-positive risk:  671 713 100 1070 427 98 1089 418 145 49 164 56 
H-negative risk:  713 671 1089 1070 418 427 98 100 164 145 56 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 95 13 

clinical_engagement 
diagnosis 
demography 
70 new agents 
194 
disease_progression 
H-positive risk:  671 705 102 1070 429 101 1086 424 141 50 164 57 
H-negative risk:  705 671 1086 1070 424 429 101 102 164 141 57 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 98 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
195 
disease_progression 
H-positive risk:  666 708 104 1059 439 102 1089 426 135 50 162 60 
H-negative risk:  708 666 1089 1059 426 439 102 104 162 135 60 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 99 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
196 
disease_progression 
H-positive risk:  660 703 107 1066 437 103 1091 427 132 51 163 60 
H-negative risk:  703 660 1091 1066 427 437 103 107 163 132 60 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 98 12 

clinical_engagement 
diagnosis 
demography 
80 new agents 
197 
disease_progression 
H-positive risk:  657 711 107 1060 439 100 1092 435 131 49 163 56 
H-negative risk:  711 657 1092 1060 435 439 100 107 163 131 56 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 100 12 

clinical_engagement 
diagnosis 
demography 
96 new agents 
198 
disease_progression 
H-positive risk:  653 714 109 1064 433 98 1098 431 131 49 166 54 
H-negative risk:  714 653 1098 1064 431 433 98 109 166 131 54 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 101 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
199 
disease_progression 
H-positive risk:  655 720 107 1058 432 96 1099 426 134 49 171 53 
H-negative risk:  720 655 1099 1058 426 432 96 107 171 134 53 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 102 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
200 
disease_progression 
H-positive risk:  663 714 104 1068 430 98 1091 422 134 46 176 54 
H-negative risk:  714 663 1091 1068 422 430 98 104 176 134 54 46 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 101 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
201 
disease_progression 
H-positive risk:  670 713 104 1075 423 97 1078 425 135 44 181 55 
H-negative risk:  713 670 1078 1075 425 423 97 104 181 135 55 44 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 101 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
202 
disease_progression 
H-positive risk:  672 706 102 1091 418 96 1076 418 139 44 184 54 
H-negative risk:  706 672 1076 1091 418 418 96 102 184 139 54 44 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
91 new agents 
203 
disease_progression 
H-positive risk:  672 704 98 1099 419 97 1080 414 133 47 184 53 
H-negative risk:  704 672 1080 1099 414 419 97 98 184 133 53 47 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
204 
disease_progression 
H-positive risk:  673 698 97 1106 411 97 1083 419 131 49 184 52 
H-negative risk:  698 673 1083 1106 419 411 97 97 184 131 52 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
205 
disease_progression 
H-positive risk:  673 701 96 1097 410 97 1084 429 129 48 184 52 
H-negative risk:  701 673 1084 1097 429 410 97 96 184 129 52 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
206 
disease_progression 
H-positive risk:  683 702 95 1088 413 95 1080 425 135 49 182 53 
H-negative risk:  702 683 1080 1088 425 413 95 95 182 135 53 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
84 new agents 
207 
disease_progression 
H-positive risk:  677 706 97 1093 402 97 1069 437 139 50 176 57 
H-negative risk:  706 677 1069 1093 437 402 97 97 176 139 57 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
208 
disease_progression 
H-positive risk:  671 698 97 1113 397 95 1066 439 140 52 176 56 
H-negative risk:  698 671 1066 1113 439 397 95 97 176 140 56 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
209 
disease_progression 
H-positive risk:  668 695 97 1110 412 93 1062 440 142 52 174 55 
H-negative risk:  695 668 1062 1110 440 412 93 97 174 142 55 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
210 
disease_progression 
H-positive risk:  663 690 98 1110 421 91 1058 445 147 48 174 55 
H-negative risk:  690 663 1058 1110 445 421 91 98 174 147 55 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
211 
disease_progression 
H-positive risk:  665 689 99 1104 427 89 1061 440 148 45 176 57 
H-negative risk:  689 665 1061 1104 440 427 89 99 176 148 57 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
212 
disease_progression 
H-positive risk:  661 690 99 1118 422 90 1059 440 145 45 175 56 
H-negative risk:  690 661 1059 1118 440 422 90 99 175 145 56 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
213 
disease_progression 
H-positive risk:  660 677 102 1132 418 88 1071 436 144 42 175 55 
H-negative risk:  677 660 1071 1132 436 418 88 102 175 144 55 42 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
214 
disease_progression 
H-positive risk:  657 676 101 1133 420 87 1075 434 144 44 174 55 
H-negative risk:  676 657 1075 1133 434 420 87 101 174 144 55 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
215 
disease_progression 
H-positive risk:  653 677 99 1127 426 85 1084 429 145 45 178 52 
H-negative risk:  677 653 1084 1127 429 426 85 99 178 145 52 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
216 
disease_progression 
H-positive risk:  658 681 95 1132 414 85 1080 430 148 45 176 56 
H-negative risk:  681 658 1080 1132 430 414 85 95 176 148 56 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
217 
disease_progression 
H-positive risk:  658 681 96 1111 428 83 1080 436 150 47 176 54 
H-negative risk:  681 658 1080 1111 436 428 83 96 176 150 54 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
218 
disease_progression 
H-positive risk:  660 677 96 1128 426 83 1078 425 150 46 177 54 
H-negative risk:  677 660 1078 1128 425 426 83 96 177 150 54 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
219 
disease_progression 
H-positive risk:  652 681 92 1136 418 86 1083 425 151 47 175 54 
H-negative risk:  681 652 1083 1136 425 418 86 92 175 151 54 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
220 
disease_progression 
H-positive risk:  657 684 95 1130 419 88 1078 425 147 49 173 55 
H-negative risk:  684 657 1078 1130 425 419 88 95 173 147 55 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
221 
disease_progression 
H-positive risk:  668 684 96 1122 419 90 1074 424 147 50 173 53 
H-negative risk:  684 668 1074 1122 424 419 90 96 173 147 53 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
222 
disease_progression 
H-positive risk:  669 682 95 1131 413 90 1072 428 147 49 170 54 
H-negative risk:  682 669 1072 1131 428 413 90 95 170 147 54 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
223 
disease_progression 
H-positive risk:  678 681 96 1133 414 91 1061 426 147 52 170 51 
H-negative risk:  681 678 1061 1133 426 414 91 96 170 147 51 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
224 
disease_progression 
H-positive risk:  675 680 98 1130 410 92 1060 432 148 54 170 51 
H-negative risk:  680 675 1060 1130 432 410 92 98 170 148 51 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
225 
disease_progression 
H-positive risk:  671 688 95 1142 408 88 1062 421 150 56 170 49 
H-negative risk:  688 671 1062 1142 421 408 88 95 170 150 49 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
226 
disease_progression 
H-positive risk:  676 687 91 1144 417 89 1058 416 148 54 170 50 
H-negative risk:  687 676 1058 1144 416 417 89 91 170 148 50 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
227 
disease_progression 
H-positive risk:  671 684 91 1154 418 88 1060 409 150 53 170 52 
H-negative risk:  684 671 1060 1154 409 418 88 91 170 150 52 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
228 
disease_progression 
H-positive risk:  665 691 91 1149 417 91 1063 407 151 54 171 50 
H-negative risk:  691 665 1063 1149 407 417 91 91 171 151 50 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
229 
disease_progression 
H-positive risk:  670 693 90 1130 425 88 1056 415 153 58 166 56 
H-negative risk:  693 670 1056 1130 415 425 88 90 166 153 56 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
230 
disease_progression 
H-positive risk:  672 697 90 1125 423 87 1053 418 158 55 167 55 
H-negative risk:  697 672 1053 1125 418 423 87 90 167 158 55 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
231 
disease_progression 
H-positive risk:  666 698 87 1120 429 86 1062 419 161 53 167 52 
H-negative risk:  698 666 1062 1120 419 429 86 87 167 161 52 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
232 
disease_progression 
H-positive risk:  666 691 87 1116 434 87 1067 418 161 50 170 53 
H-negative risk:  691 666 1067 1116 418 434 87 87 170 161 53 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
233 
disease_progression 
H-positive risk:  667 688 88 1114 434 89 1076 416 156 47 169 56 
H-negative risk:  688 667 1076 1114 416 434 89 88 169 156 56 47 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
234 
disease_progression 
H-positive risk:  666 685 88 1106 437 90 1070 426 155 50 170 57 
H-negative risk:  685 666 1070 1106 426 437 90 88 170 155 57 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 101 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
235 
disease_progression 
H-positive risk:  659 686 90 1107 437 90 1075 421 157 52 167 59 
H-negative risk:  686 659 1075 1107 421 437 90 90 167 157 59 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
53 new agents 
236 
disease_progression 
H-positive risk:  653 679 91 1111 440 89 1086 418 156 51 167 59 
H-negative risk:  679 653 1086 1111 418 440 89 91 167 156 59 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 98 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
237 
disease_progression 
H-positive risk:  654 682 92 1099 442 87 1087 420 159 52 165 61 
H-negative risk:  682 654 1087 1099 420 442 87 92 165 159 61 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
238 
disease_progression 
H-positive risk:  653 684 92 1096 444 87 1082 420 159 55 166 62 
H-negative risk:  684 653 1082 1096 420 444 87 92 166 159 62 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 97 19 

clinical_engagement 
diagnosis 
demography 
59 new agents 
239 
disease_progression 
H-positive risk:  657 682 92 1093 445 89 1074 427 159 55 166 61 
H-negative risk:  682 657 1074 1093 427 445 89 92 166 159 61 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
240 
disease_progression 
H-positive risk:  658 684 90 1107 441 88 1076 422 155 54 166 59 
H-negative risk:  684 658 1076 1107 422 441 88 90 166 155 59 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
241 
disease_progression 
H-positive risk:  663 681 93 1099 449 87 1072 422 155 54 164 61 
H-negative risk:  681 663 1072 1099 422 449 87 93 164 155 61 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
242 
disease_progression 
H-positive risk:  654 676 91 1101 450 90 1088 416 154 53 166 61 
H-negative risk:  676 654 1088 1101 416 450 90 91 166 154 61 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
243 
disease_progression 
H-positive risk:  649 677 91 1100 459 88 1086 411 156 54 168 61 
H-negative risk:  677 649 1086 1100 411 459 88 91 168 156 61 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
244 
disease_progression 
H-positive risk:  647 684 87 1092 460 89 1084 415 154 53 172 63 
H-negative risk:  684 647 1084 1092 415 460 89 87 172 154 63 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
245 
disease_progression 
H-positive risk:  648 682 85 1092 463 87 1078 420 155 57 172 61 
H-negative risk:  682 648 1078 1092 420 463 87 85 172 155 61 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
246 
disease_progression 
H-positive risk:  651 684 85 1094 468 86 1078 410 155 57 169 63 
H-negative risk:  684 651 1078 1094 410 468 86 85 169 155 63 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
247 
disease_progression 
H-positive risk:  658 684 83 1090 467 88 1065 421 152 57 170 65 
H-negative risk:  684 658 1065 1090 421 467 88 83 170 152 65 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
248 
disease_progression 
H-positive risk:  657 691 81 1083 460 84 1069 424 157 58 172 64 
H-negative risk:  691 657 1069 1083 424 460 84 81 172 157 64 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
249 
disease_progression 
H-positive risk:  651 696 84 1081 465 86 1072 418 153 60 171 63 
H-negative risk:  696 651 1072 1081 418 465 86 84 171 153 63 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
250 
disease_progression 
H-positive risk:  649 690 86 1085 460 87 1082 424 150 62 168 57 
H-negative risk:  690 649 1082 1085 424 460 87 86 168 150 57 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
251 
disease_progression 
H-positive risk:  642 691 89 1094 451 86 1093 422 153 59 166 54 
H-negative risk:  691 642 1093 1094 422 451 86 89 166 153 54 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
252 
disease_progression 
H-positive risk:  639 694 91 1087 452 82 1097 427 151 60 163 57 
H-negative risk:  694 639 1097 1087 427 452 82 91 163 151 57 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
253 
disease_progression 
H-positive risk:  637 694 92 1078 455 84 1098 436 143 58 163 62 
H-negative risk:  694 637 1098 1078 436 455 84 92 163 143 62 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
92 new agents 
254 
disease_progression 
H-positive risk:  636 698 95 1074 451 81 1106 430 149 57 161 62 
H-negative risk:  698 636 1106 1074 430 451 81 95 161 149 62 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
255 
disease_progression 
H-positive risk:  636 699 97 1075 445 81 1108 431 151 55 164 58 
H-negative risk:  699 636 1108 1075 431 445 81 97 164 151 58 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
256 
disease_progression 
H-positive risk:  642 697 99 1069 444 80 1107 427 151 57 166 61 
H-negative risk:  697 642 1107 1069 427 444 80 99 166 151 61 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
257 
disease_progression 
H-positive risk:  643 697 99 1070 446 81 1103 427 146 58 168 62 
H-negative risk:  697 643 1103 1070 427 446 81 99 168 146 62 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
258 
disease_progression 
H-positive risk:  643 711 95 1063 437 80 1107 429 143 60 168 64 
H-negative risk:  711 643 1107 1063 429 437 80 95 168 143 64 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
259 
disease_progression 
H-positive risk:  646 709 95 1055 429 83 1113 432 140 64 169 65 
H-negative risk:  709 646 1113 1055 432 429 83 95 169 140 65 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
260 
disease_progression 
H-positive risk:  643 714 97 1053 431 84 1115 434 142 62 160 65 
H-negative risk:  714 643 1115 1053 434 431 84 97 160 142 65 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
261 
disease_progression 
H-positive risk:  653 705 92 1057 431 85 1118 433 141 63 157 65 
H-negative risk:  705 653 1118 1057 433 431 85 92 157 141 65 63 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 94 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
262 
disease_progression 
H-positive risk:  660 704 94 1063 429 88 1115 424 140 64 156 63 
H-negative risk:  704 660 1115 1063 424 429 88 94 156 140 63 64 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
98 new agents 
263 
disease_progression 
H-positive risk:  664 708 97 1054 421 91 1119 419 142 64 157 64 
H-negative risk:  708 664 1119 1054 419 421 91 97 157 142 64 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 91 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
264 
disease_progression 
H-positive risk:  656 714 97 1053 420 90 1127 421 143 63 156 60 
H-negative risk:  714 656 1127 1053 421 420 90 97 156 143 60 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
265 
disease_progression 
H-positive risk:  662 712 96 1043 426 89 1132 421 145 59 156 59 
H-negative risk:  712 662 1132 1043 421 426 89 96 156 145 59 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 91 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
266 
disease_progression 
H-positive risk:  657 715 96 1047 430 86 1130 423 146 57 155 58 
H-negative risk:  715 657 1130 1047 423 430 86 96 155 146 58 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
267 
disease_progression 
H-positive risk:  659 716 98 1049 429 82 1133 419 146 55 157 57 
H-negative risk:  716 659 1133 1049 419 429 82 98 157 146 57 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
268 
disease_progression 
H-positive risk:  654 719 97 1051 419 82 1141 416 148 56 160 57 
H-negative risk:  719 654 1141 1051 416 419 82 97 160 148 57 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
269 
disease_progression 
H-positive risk:  646 725 93 1058 416 81 1146 414 148 56 161 56 
H-negative risk:  725 646 1146 1058 414 416 81 93 161 148 56 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
270 
disease_progression 
H-positive risk:  641 720 90 1063 419 81 1149 413 147 56 164 57 
H-negative risk:  720 641 1149 1063 413 419 81 90 164 147 57 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
271 
disease_progression 
H-positive risk:  638 719 89 1061 412 79 1151 420 150 57 168 56 
H-negative risk:  719 638 1151 1061 420 412 79 89 168 150 56 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 97 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
272 
disease_progression 
H-positive risk:  640 714 93 1061 420 79 1152 411 149 57 170 54 
H-negative risk:  714 640 1152 1061 411 420 79 93 170 149 54 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 97 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
273 
disease_progression 
H-positive risk:  640 703 93 1063 428 79 1159 406 146 58 169 56 
H-negative risk:  703 640 1159 1063 406 428 79 93 169 146 56 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
274 
disease_progression 
H-positive risk:  647 698 93 1066 422 82 1157 412 143 56 168 56 
H-negative risk:  698 647 1157 1066 412 422 82 93 168 143 56 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
275 
disease_progression 
H-positive risk:  646 699 91 1066 437 80 1152 403 145 56 169 56 
H-negative risk:  699 646 1152 1066 403 437 80 91 169 145 56 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
276 
disease_progression 
H-positive risk:  656 710 89 1064 434 79 1145 397 145 56 169 56 
H-negative risk:  710 656 1145 1064 397 434 79 89 169 145 56 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
277 
disease_progression 
H-positive risk:  656 703 90 1072 429 78 1149 399 145 58 164 57 
H-negative risk:  703 656 1149 1072 399 429 78 90 164 145 57 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
278 
disease_progression 
H-positive risk:  659 695 93 1067 432 77 1148 405 146 58 164 56 
H-negative risk:  695 659 1148 1067 405 432 77 93 164 146 56 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
279 
disease_progression 
H-positive risk:  657 695 92 1058 436 77 1153 403 147 61 164 57 
H-negative risk:  695 657 1153 1058 403 436 77 92 164 147 57 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
280 
disease_progression 
H-positive risk:  659 702 93 1061 433 78 1144 408 146 59 159 58 
H-negative risk:  702 659 1144 1061 408 433 78 93 159 146 58 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
281 
disease_progression 
H-positive risk:  654 704 94 1063 430 79 1153 410 148 56 153 56 
H-negative risk:  704 654 1153 1063 410 430 79 94 153 148 56 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
282 
disease_progression 
H-positive risk:  658 701 92 1068 428 79 1150 411 148 56 154 55 
H-negative risk:  701 658 1150 1068 411 428 79 92 154 148 55 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
283 
disease_progression 
H-positive risk:  661 703 95 1067 431 78 1150 407 143 56 155 54 
H-negative risk:  703 661 1150 1067 407 431 78 95 155 143 54 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
284 
disease_progression 
H-positive risk:  657 706 96 1058 433 77 1156 409 144 54 155 55 
H-negative risk:  706 657 1156 1058 409 433 77 96 155 144 55 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
285 
disease_progression 
H-positive risk:  657 708 98 1049 438 77 1141 425 143 56 154 54 
H-negative risk:  708 657 1141 1049 425 438 77 98 154 143 54 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
286 
disease_progression 
H-positive risk:  665 698 97 1060 429 76 1138 431 144 56 153 53 
H-negative risk:  698 665 1138 1060 431 429 76 97 153 144 53 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
287 
disease_progression 
H-positive risk:  661 709 99 1056 424 74 1142 428 144 54 155 54 
H-negative risk:  709 661 1142 1056 428 424 74 99 155 144 54 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
288 
disease_progression 
H-positive risk:  656 699 96 1069 427 75 1146 431 139 53 156 53 
H-negative risk:  699 656 1146 1069 431 427 75 96 156 139 53 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
289 
disease_progression 
H-positive risk:  662 699 99 1073 426 76 1136 429 139 53 154 54 
H-negative risk:  699 662 1136 1073 429 426 76 99 154 139 54 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
290 
disease_progression 
H-positive risk:  661 698 100 1074 415 75 1143 427 146 53 154 54 
H-negative risk:  698 661 1143 1074 427 415 75 100 154 146 54 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
291 
disease_progression 
H-positive risk:  662 696 98 1070 415 75 1145 429 145 53 154 58 
H-negative risk:  696 662 1145 1070 429 415 75 98 154 145 58 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
292 
disease_progression 
H-positive risk:  667 698 100 1065 405 76 1152 429 146 51 154 57 
H-negative risk:  698 667 1152 1065 429 405 76 100 154 146 57 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
293 
disease_progression 
H-positive risk:  678 698 98 1059 397 75 1151 430 151 51 151 61 
H-negative risk:  698 678 1151 1059 430 397 75 98 151 151 61 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
294 
disease_progression 
H-positive risk:  679 697 98 1050 407 76 1145 435 150 47 154 62 
H-negative risk:  697 679 1145 1050 435 407 76 98 154 150 62 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
295 
disease_progression 
H-positive risk:  682 688 105 1056 401 74 1143 430 154 47 157 63 
H-negative risk:  688 682 1143 1056 430 401 74 105 157 154 63 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
296 
disease_progression 
H-positive risk:  684 683 104 1057 400 75 1153 424 152 50 154 64 
H-negative risk:  683 684 1153 1057 424 400 75 104 154 152 64 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
297 
disease_progression 
H-positive risk:  685 685 103 1056 410 74 1143 428 148 51 152 65 
H-negative risk:  685 685 1143 1056 428 410 74 103 152 148 65 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
298 
disease_progression 
H-positive risk:  673 689 105 1059 411 77 1141 435 146 51 148 65 
H-negative risk:  689 673 1141 1059 435 411 77 105 148 146 65 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
299 
disease_progression 
H-positive risk:  677 687 106 1053 417 79 1137 433 147 50 147 67 
H-negative risk:  687 677 1137 1053 433 417 79 106 147 147 67 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
300 
disease_progression 
H-positive risk:  677 685 106 1055 417 80 1136 433 146 53 145 67 
H-negative risk:  685 677 1136 1055 433 417 80 106 145 146 67 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
301 
disease_progression 
H-positive risk:  675 693 107 1055 413 79 1133 435 146 53 146 65 
H-negative risk:  693 675 1133 1055 435 413 79 107 146 146 65 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
302 
disease_progression 
H-positive risk:  668 692 103 1056 416 79 1142 434 146 50 150 64 
H-negative risk:  692 668 1142 1056 434 416 79 103 150 146 64 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
303 
disease_progression 
H-positive risk:  673 701 101 1041 413 78 1143 437 148 50 149 66 
H-negative risk:  701 673 1143 1041 437 413 78 101 149 148 66 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
304 
disease_progression 
H-positive risk:  674 699 97 1047 420 78 1139 431 148 51 149 67 
H-negative risk:  699 674 1139 1047 431 420 78 97 149 148 67 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
305 
disease_progression 
H-positive risk:  681 700 95 1039 420 77 1143 429 149 52 149 66 
H-negative risk:  700 681 1143 1039 429 420 77 95 149 149 66 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
306 
disease_progression 
H-positive risk:  689 701 93 1041 422 79 1131 436 144 51 149 64 
H-negative risk:  701 689 1131 1041 436 422 79 93 149 144 64 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
307 
disease_progression 
H-positive risk:  685 707 93 1041 420 80 1131 436 144 52 148 63 
H-negative risk:  707 685 1131 1041 436 420 80 93 148 144 63 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
308 
disease_progression 
H-positive risk:  686 694 94 1059 416 80 1128 436 144 53 144 66 
H-negative risk:  694 686 1128 1059 436 416 80 94 144 144 66 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
309 
disease_progression 
H-positive risk:  686 694 89 1055 417 83 1136 434 142 53 146 65 
H-negative risk:  694 686 1136 1055 434 417 83 89 146 142 65 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
310 
disease_progression 
H-positive risk:  688 695 91 1059 416 84 1135 430 143 51 145 63 
H-negative risk:  695 688 1135 1059 430 416 84 91 145 143 63 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
311 
disease_progression 
H-positive risk:  689 692 89 1061 421 84 1132 431 141 50 149 61 
H-negative risk:  692 689 1132 1061 431 421 84 89 149 141 61 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
312 
disease_progression 
H-positive risk:  682 685 87 1077 419 81 1130 438 142 50 148 61 
H-negative risk:  685 682 1130 1077 438 419 81 87 148 142 61 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
313 
disease_progression 
H-positive risk:  676 675 86 1085 419 83 1145 433 140 48 149 61 
H-negative risk:  675 676 1145 1085 433 419 83 86 149 140 61 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
94 new agents 
314 
disease_progression 
H-positive risk:  675 678 86 1082 420 80 1149 433 139 48 151 59 
H-negative risk:  678 675 1149 1082 433 420 80 86 151 139 59 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
315 
disease_progression 
H-positive risk:  669 677 85 1090 414 80 1151 437 140 47 148 62 
H-negative risk:  677 669 1151 1090 437 414 80 85 148 140 62 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
316 
disease_progression 
H-positive risk:  670 681 83 1086 420 79 1139 442 142 45 150 63 
H-negative risk:  681 670 1139 1086 442 420 79 83 150 142 63 45 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
317 
disease_progression 
H-positive risk:  672 680 83 1088 423 80 1134 445 137 45 150 63 
H-negative risk:  680 672 1134 1088 445 423 80 83 150 137 63 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
318 
disease_progression 
H-positive risk:  674 677 83 1082 429 81 1128 445 139 47 149 66 
H-negative risk:  677 674 1128 1082 445 429 81 83 149 139 66 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
99 new agents 
319 
disease_progression 
H-positive risk:  681 681 80 1079 427 86 1124 438 136 50 153 65 
H-negative risk:  681 681 1124 1079 438 427 86 80 153 136 65 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
95 new agents 
320 
disease_progression 
H-positive risk:  690 682 77 1070 427 89 1112 443 138 51 155 66 
H-negative risk:  682 690 1112 1070 443 427 89 77 155 138 66 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
321 
disease_progression 
H-positive risk:  690 684 78 1075 426 91 1102 447 137 51 155 64 
H-negative risk:  684 690 1102 1075 447 426 91 78 155 137 64 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
322 
disease_progression 
H-positive risk:  686 686 78 1078 419 90 1099 452 140 52 157 63 
H-negative risk:  686 686 1099 1078 452 419 90 78 157 140 63 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
99 new agents 
323 
disease_progression 
H-positive risk:  692 676 78 1083 434 91 1098 438 140 55 153 62 
H-negative risk:  676 692 1098 1083 438 434 91 78 153 140 62 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
324 
disease_progression 
H-positive risk:  682 671 77 1093 430 91 1100 441 141 54 157 63 
H-negative risk:  671 682 1100 1093 441 430 91 77 157 141 63 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
325 
disease_progression 
H-positive risk:  686 668 74 1086 428 93 1102 442 142 54 163 62 
H-negative risk:  668 686 1102 1086 442 428 93 74 163 142 62 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
326 
disease_progression 
H-positive risk:  678 680 72 1090 412 96 1107 443 140 54 165 63 
H-negative risk:  680 678 1107 1090 443 412 96 72 165 140 63 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
327 
disease_progression 
H-positive risk:  684 674 73 1097 404 99 1103 435 138 58 171 64 
H-negative risk:  674 684 1103 1097 435 404 99 73 171 138 64 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
328 
disease_progression 
H-positive risk:  677 672 72 1094 408 97 1109 437 137 61 169 67 
H-negative risk:  672 677 1109 1094 437 408 97 72 169 137 67 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
329 
disease_progression 
H-positive risk:  677 674 74 1103 407 97 1114 426 134 60 165 69 
H-negative risk:  674 677 1114 1103 426 407 97 74 165 134 69 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
57 new agents 
330 
disease_progression 
H-positive risk:  675 676 78 1105 401 97 1113 431 135 57 165 67 
H-negative risk:  676 675 1113 1105 431 401 97 78 165 135 67 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
94 new agents 
331 
disease_progression 
H-positive risk:  671 675 80 1097 413 97 1116 431 133 59 164 64 
H-negative risk:  675 671 1116 1097 431 413 97 80 164 133 64 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
332 
disease_progression 
H-positive risk:  672 673 80 1087 411 99 1116 433 134 60 166 69 
H-negative risk:  673 672 1116 1087 433 411 99 80 166 134 69 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
333 
disease_progression 
H-positive risk:  667 671 78 1093 404 102 1114 441 132 61 170 67 
H-negative risk:  671 667 1114 1093 441 404 102 78 170 132 67 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
334 
disease_progression 
H-positive risk:  671 672 76 1091 412 103 1106 440 130 62 169 68 
H-negative risk:  672 671 1106 1091 440 412 103 76 169 130 68 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
335 
disease_progression 
H-positive risk:  673 678 77 1086 414 101 1101 434 131 63 171 71 
H-negative risk:  678 673 1101 1086 434 414 101 77 171 131 71 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
336 
disease_progression 
H-positive risk:  676 671 77 1085 418 101 1104 435 133 63 164 73 
H-negative risk:  671 676 1104 1085 435 418 101 77 164 133 73 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
337 
disease_progression 
H-positive risk:  679 671 76 1085 424 100 1102 432 136 61 161 73 
H-negative risk:  671 679 1102 1085 432 424 100 76 161 136 73 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
338 
disease_progression 
H-positive risk:  672 668 76 1086 425 102 1100 444 136 59 160 72 
H-negative risk:  668 672 1100 1086 444 425 102 76 160 136 72 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
88 new agents 
339 
disease_progression 
H-positive risk:  672 679 73 1089 408 105 1105 449 131 59 160 70 
H-negative risk:  679 672 1105 1089 449 408 105 73 160 131 70 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
340 
disease_progression 
H-positive risk:  667 681 75 1086 420 106 1102 445 129 59 160 70 
H-negative risk:  681 667 1102 1086 445 420 106 75 160 129 70 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
341 
disease_progression 
H-positive risk:  661 680 74 1100 414 106 1107 441 127 61 163 66 
H-negative risk:  680 661 1107 1100 441 414 106 74 163 127 66 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
342 
disease_progression 
H-positive risk:  657 683 73 1105 410 106 1115 436 127 61 163 64 
H-negative risk:  683 657 1115 1105 436 410 106 73 163 127 64 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
343 
disease_progression 
H-positive risk:  656 677 74 1107 421 106 1115 430 129 59 163 63 
H-negative risk:  677 656 1115 1107 430 421 106 74 163 129 63 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
344 
disease_progression 
H-positive risk:  662 687 75 1105 422 107 1112 420 128 61 161 60 
H-negative risk:  687 662 1112 1105 420 422 107 75 161 128 60 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
345 
disease_progression 
H-positive risk:  664 692 76 1104 415 107 1109 419 128 62 164 60 
H-negative risk:  692 664 1109 1104 419 415 107 76 164 128 60 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
346 
disease_progression 
H-positive risk:  656 685 72 1110 418 106 1123 413 129 61 167 60 
H-negative risk:  685 656 1123 1110 413 418 106 72 167 129 60 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
347 
disease_progression 
H-positive risk:  650 684 73 1110 417 107 1120 421 131 61 165 61 
H-negative risk:  684 650 1120 1110 421 417 107 73 165 131 61 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
348 
disease_progression 
H-positive risk:  650 681 77 1107 420 106 1123 422 132 61 161 60 
H-negative risk:  681 650 1123 1107 422 420 106 77 161 132 60 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
349 
disease_progression 
H-positive risk:  652 693 80 1113 413 105 1109 425 128 62 158 62 
H-negative risk:  693 652 1109 1113 425 413 105 80 158 128 62 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
350 
disease_progression 
H-positive risk:  650 688 81 1114 415 105 1118 422 126 62 159 60 
H-negative risk:  688 650 1118 1114 422 415 105 81 159 126 60 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
96 new agents 
351 
disease_progression 
H-positive risk:  660 687 80 1110 417 108 1119 410 125 62 164 58 
H-negative risk:  687 660 1119 1110 410 417 108 80 164 125 58 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
352 
disease_progression 
H-positive risk:  657 691 80 1115 417 109 1117 403 127 62 164 58 
H-negative risk:  691 657 1117 1115 403 417 109 80 164 127 58 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
353 
disease_progression 
H-positive risk:  662 687 79 1119 414 109 1118 401 128 63 161 59 
H-negative risk:  687 662 1118 1119 401 414 109 79 161 128 59 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
354 
disease_progression 
H-positive risk:  662 691 79 1110 417 109 1118 401 128 64 159 62 
H-negative risk:  691 662 1118 1110 401 417 109 79 159 128 62 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
355 
disease_progression 
H-positive risk:  655 693 79 1102 410 113 1131 402 128 62 163 62 
H-negative risk:  693 655 1131 1102 402 410 113 79 163 128 62 62 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
356 
disease_progression 
H-positive risk:  646 692 77 1100 417 110 1135 405 131 62 161 64 
H-negative risk:  692 646 1135 1100 405 417 110 77 161 131 64 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
357 
disease_progression 
H-positive risk:  645 688 76 1101 418 109 1145 405 134 61 158 60 
H-negative risk:  688 645 1145 1101 405 418 109 76 158 134 60 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
358 
disease_progression 
H-positive risk:  646 696 75 1101 417 108 1140 407 132 62 159 57 
H-negative risk:  696 646 1140 1101 407 417 108 75 159 132 57 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
359 
disease_progression 
H-positive risk:  652 690 78 1099 409 110 1141 416 132 59 158 56 
H-negative risk:  690 652 1141 1099 416 409 110 78 158 132 56 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
91 new agents 
360 
disease_progression 
H-positive risk:  656 697 78 1091 413 112 1133 418 131 59 161 51 
H-negative risk:  697 656 1133 1091 418 413 112 78 161 131 51 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
Time difference of 17.49238 mins
This is task 9
